Could CVS Health be the Next Company to do a Tax Inversion Deal?
CVS Health president and chief executive Larry Merlo reveals to TheStreet's Brittany Umar whether a tax inversion deal could be in the company's future.
CVS Health president and chief executive Larry Merlo reveals to TheStreet's Brittany Umar whether a tax inversion deal could be in the company's future. The company just announced it's pulling tobacco products out of stores today, a month earlier than planned, and changing its name from CVS Caremark to CVS Health. After ringing the opening bell at the New York Stock Exchange, Merlo explains what lead to the company's decision to remove tobacco products sooner than expected and how its smoking cessation segment is growing. Merlo also reveals how ending tobacco sales will impact CVS' ability to partner with traditional health care providers in the era of the Affordable Care Act.









